Poly-l-Lactic Acid for Body Treatment

  • Daniel Dal’Asta CoimbraEmail author
  • Betina Stefanello de Oliveira
  • Natalia Caballero Uribe
Living reference work entry

Latest version View entry history

Part of the Clinical Approaches and Procedures in Cosmetic Dermatology book series (CAPCD)


The poly-l-lactic acid (PLLA) injection technique stimulates neocollagenesis and provides a natural look. In recent years there has been a growing interest for using this in other body areas such as the neck, chest, back of the hands, lower breast region, thoraco-axillary fold, buttocks, arms, and medial thighs. There is no clear consensus regarding the best dilution or application techniques for the face and the body, and the description in this article is based on the authors’ experience. In this chapter I will approach a new technique for body areas and the dilution of the quantity of the product per application. The application of PLLA for rejuvenation of body areas is a minimally invasive procedure, with durable and low frequency of complications.


Poly-l-lactic acid Body area Technique Rejuvenation Minimally invasive procedure 


  1. Bos RRM, Rozema FR, Boering G, et al. Degradation of and tissue reaction to biodegradable poly(l-lactide) for use as internal fixation of fractures: a study in rats. Biomaterials. 1991;12:32–6.PubMedGoogle Scholar
  2. Burgess CM, Quiroga RM. Assessment of the safety and efficacy of poly-l-lactic acid for the treatment of HIV-associated facial lipoatrophy. J Am Acad Dermatol. 2005;52:233–9.PubMedGoogle Scholar
  3. Coimbra D., Amorim AGF. Ácido Poli-l-láctico na região medial dos braços. Surg Cosm Dermatol. n.d.Google Scholar
  4. Distante F, Pagani V, Bonfigli A. Stabilized hyaluronic acid of non-animal origin for rejuvenating the skin of the upper arm. Dermatol Surg. 2009;35(Suppl 1):389–93.Google Scholar
  5. Duffy DM. Complications of fillers: overview. Dermatol Surg. 2005;31:1626–33.PubMedGoogle Scholar
  6. Duracinsky M, Leclercq P, Herrmann S, Christen MO, Dolivo M, Goujard C, et al. Safety of poly-l-lactic acid (New-Fill®) in the treatment of facial lipoatrophy: a large observational study among HIV-positive patients. BMC Infect Dis. 2014;14(474)Google Scholar
  7. Fitzgerald R, Vleggaar D. Facial volume restoration of the aging face with poly-l-lactic acid. Dermatol Ther. 2011;24:2–27.PubMedGoogle Scholar
  8. Gladstone HB, Cohen JL. Adverse effects when injecting facial fillers. Semin Cutan Med Surg. 2007;26:34–9.PubMedGoogle Scholar
  9. Gogolewski S, Jovanovic M, Perren SM, et al. Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). J Biomed Mater Res. 1993;27:1135–48.PubMedGoogle Scholar
  10. Lam SM, Azizzadeh B, Graivier M. Injectable poly-l-lactic acid (Sculptra): technical considerations in soft- tissue contouring. Plast Reconstr Surg. 2006;118:55S–63S.PubMedGoogle Scholar
  11. Lemperle G, Morhenn V, Charrier U. Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesthet Plast Surg. 2003;27:354–66.Google Scholar
  12. Lowe NJ. Optimizing poly-l-lactic acid use. J Cosmet Laser Ther. 2008;10:43–6.PubMedGoogle Scholar
  13. Lowe NJ, Maxwell CA, Lowe P, Shah A, Patnaik R. Adverse reactions to dermal fillers: review. Dermatol Surg. 2005;31(11 pt 2):1616–25.Google Scholar
  14. Lowe NJ, Maxwell CA, Lowe P, Shah A, Patnaik R. Injectable poly-l-lactic acid: 3 years of aesthetic experience. Dermatol Surg. 2009;35(Suppl 1):344–9.PubMedGoogle Scholar
  15. Mandy SH. Fillers that work by fibroplasia: poly-l-lactic acid. In: Carruthers J, Carruthers A, editors. Soft tissue augmentation. 2nd ed. New York: Saunders; 2007. p. 101–4.Google Scholar
  16. Mandy SH. Satisfying patient expectations with soft-tissue augmentation. Dermatol Online J. n.d.;15(7):1.Google Scholar
  17. Mazzuco R, Hexsel D. Poly-l-lactic acid for neck and chest rejuvenation. Dermatol Surg. 2009;35(8):1228–37.PubMedGoogle Scholar
  18. Mazzuco R, Sadick NS. The use of poly-l-lactic acid in the gluteal area. Dermatol Surg. 2016;42(3):441–3.PubMedGoogle Scholar
  19. Mest DR, Humble G. Safety and efficacy of poly-l-lactic acid injections in persons with HIV-associated lipoatrophy: the US experience. Dermatol Surg. 2006;32:1336–45.PubMedGoogle Scholar
  20. Murad A, Hayes G, Edward MK, Jack PMJ, Keyvan N, Isaac MN, et al. ASDS guidelines of care: injectable fillers. Dermatol Surg. 2008;34(Suppl 1):115–48.Google Scholar
  21. Palm MD, Woodhall KE, Butterwick KJ, Goldman MP. Cosmetic use of Poly-l-lactic acid: a retrospective study of 130 patients. Dermatol Surg. 2010;36(2): 161–70.PubMedGoogle Scholar
  22. Peterson JD, Goldman MP. Rejuvenation of the aging chest: a review and our experience. Dermatol Surg. 2011;37(5):555–71.PubMedGoogle Scholar
  23. Radaelli A. Cosmetic use of polylactic acid for hand rejuvenation: report on 27 patients. J Cosmet Dermatol. 2006;5(3):233–8.Google Scholar
  24. Radaelli A, Forte R. Cosmetic use of polylactic acid: report of 568 patients. J Cosmet Dermatol. 2009;8(4):239–48.Google Scholar
  25. Sadick NS. Poly-l-lactic acid: a perspective from my practice. J Cosmet Dermatol. 2008;7:55–60.PubMedGoogle Scholar
  26. Sadick NS, Arruda S. The use of poly-l-lactic acid in the abdominal area. Dermatol Surg. 2016; accepted manuscript.Google Scholar
  27. Sculptra [prescribing information], Bridgewater, NJ: Dermik Laboratories; a business of sanofi-aventis U.S. LLC. 2006.Google Scholar
  28. Sherman RN. Sculptra: the new three-dimensional filler. Clin Plast Surg. 2006;33:539–50.PubMedGoogle Scholar
  29. Stein P, Vitavska O, Kind P, Hoppe W, Wieczorek H, Schurer NY. The biological basis for poly-l-lactic acid-induced augmentation. J Dermatol Sci. 2015, Scholar
  30. Teimourian B, Malekzadeh S. Rejuvenation of the upper arm. Plast Reconstr Surg. 1998;102(2):545–51. discussion 552–3PubMedGoogle Scholar
  31. Valantin MA, Aubron-Olivier C, Ghosn J, et al. Polylactic acid implants (new-fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA. AIDS. 2003;17:2471–7.PubMedGoogle Scholar
  32. Vleggaar D. Facial volumetric correction with injectable poly-l-lactic acid. Dermatol Surg. 2005;31:1511–7.PubMedGoogle Scholar
  33. Vleggaar D, Bauer U. Facial enhancement and the European experience with Sculptra (poly-l-lactic acid). J Drugs Dermatol. 2004;3:542–7.PubMedGoogle Scholar
  34. Vleggaar D, Fitzgerald R. Dermatological implications of skeletal aging: a focus on supraperiosteal volumization for perioral rejuvenation. J Drugs Dermatol. 2008;7:209–20.Google Scholar
  35. Vleggaar D, Fitzgerald R, Paul Lorenc ZP, Andrews JT, Butterwick K, Comstock J, et al. Consensus recommendations on the use of injectable poly-l-lactic acid for facial and nonfacial volumization. J Drugs Dermatol. 2014;13(suppl 4):s44–51.PubMedGoogle Scholar
  36. Woerle B, Hanke CW, Sattler G. Poly-l-lactic acid: a temporary filler for soft tissue augmentation. J Drugs Dermatol. 2004;3:385–9.PubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Daniel Dal’Asta Coimbra
    • 1
    • 2
    Email author
  • Betina Stefanello de Oliveira
    • 3
    • 4
  • Natalia Caballero Uribe
    • 3
    • 5
    • 6
  1. 1.Instituto Nacional de Infectologia da Fundação Oswaldo Cruz (Ipec-Fiocruz)Rio de JaneiroBrazil
  2. 2.Instituto de Dermatologia Professor Rubem David Azulay da Santa Casa de Misericórdia do Rio de JaneiroRio de JaneiroBrazil
  3. 3.Instituto de Dermatologia Rubem David Azulay da Santa Casa de Misericórdia do Rio de JaneiroRio de JaneiroBrazil
  4. 4.Instituto de Dermatologia Professor Rubem David Azulay da Santa Casa de Misericórdia do Rio de JaneiroRio de JaneiroBrazil
  5. 5.Dermatologic Surgeon of the Fundação de Medicina ABC, Santo AndréSão PauloBrazil
  6. 6.Clínica Aurora – Centro Especializado de Cancer de PielMedellinColombia

Personalised recommendations